84 related articles for article (PubMed ID: 25242034)
1. The mechanisms responsible for the radiosensitizing effects of sorafenib on colon cancer cells.
Kim EH; Kim MS; Jung WG
Oncol Rep; 2014 Dec; 32(6):2421-8. PubMed ID: 25242034
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib acts synergistically in combination with radiotherapy without causing intestinal damage in colorectal cancer.
Jeong YK; Kim MS; Lee JY; Kim EH; Kim W; Ha H; Jeong JH
Tumori; 2013; 99(2):176-82. PubMed ID: 23748811
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.
Dai XF; Ding J; Zhang RG; Ren JH; Ma CM; Wu G
Int J Radiat Biol; 2013 Sep; 89(9):724-31. PubMed ID: 23682582
[TBL] [Abstract][Full Text] [Related]
4. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.
Möckelmann N; Rieckmann T; Busch CJ; Becker B; Gleißner L; Hoffer K; Omniczynski M; Steinmeister L; Laban S; Grénman R; Petersen C; Rothkamm K; Dikomey E; Knecht R; Kriegs M
Oncotarget; 2016 Apr; 7(17):23542-51. PubMed ID: 27015558
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of SU5416, an inhibitor of vascular endothelial growth factor receptor, as a radiosensitizer for colon cancer cells.
Kim EH; Lee H; Jeong YK; Jung WG
Oncol Rep; 2016 Aug; 36(2):763-70. PubMed ID: 27373272
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo.
Yu W; Gu K; Yu Z; Yuan D; He M; Ma N; Lai S; Zhao J; Ren Z; Zhang X; Shao C; Jiang GL
Cancer Lett; 2013 Feb; 329(1):109-17. PubMed ID: 23142289
[TBL] [Abstract][Full Text] [Related]
7. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner.
Li Q; Hu Y; Xi M; He L; Zhao L; Liu M
BMC Cancer; 2012 Oct; 12():485. PubMed ID: 23088517
[TBL] [Abstract][Full Text] [Related]
9. Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells.
Ma H; Bi J; Liu T; Ke Y; Zhang S; Zhang T
Oncol Rep; 2015 Mar; 33(3):1161-70. PubMed ID: 25572529
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of sorafenib with ionizing radiation on human oral cancer cells.
Hsu FT; Chang B; Chiang IT; Wu TH; Hwang JJ
In Vivo; 2014; 28(5):925-33. PubMed ID: 25189909
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for SU5416 as a radiosensitizer of endothelial cells.
Kim EH; Kim MS; Jeong YK; Cho I; You SH; Cho SH; Lee H; Jung WG; Kim HD; Kim J
Int J Oncol; 2015 Oct; 47(4):1440-50. PubMed ID: 26314590
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo.
Kuo YC; Lin WC; Chiang IT; Chang YF; Chen CW; Su SH; Chen CL; Hwang JJ
Biomed Pharmacother; 2012 Feb; 66(1):12-20. PubMed ID: 22265104
[TBL] [Abstract][Full Text] [Related]
13. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
Pignochino Y; Dell'Aglio C; Basiricò M; Capozzi F; Soster M; Marchiò S; Bruno S; Gammaitoni L; Sangiolo D; Torchiaro E; D'Ambrosio L; Fagioli F; Ferrari S; Alberghini M; Picci P; Aglietta M; Grignani G
Clin Cancer Res; 2013 Apr; 19(8):2117-31. PubMed ID: 23434734
[TBL] [Abstract][Full Text] [Related]
14. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
15. Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize colorectal cancer cells to radiation.
Deorukhkar A; Ahuja N; Mercado AL; Diagaradjane P; Raju U; Patel N; Mohindra P; Diep N; Guha S; Krishnan S
Cancer Med; 2015 Feb; 4(2):278-92. PubMed ID: 25450478
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3.
Huang CY; Lin CS; Tai WT; Hsieh CY; Shiau CW; Cheng AL; Chen KF
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):456-62. PubMed ID: 23474115
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib enhances the antitumor effects of chemoradiation treatment by downregulating ERCC-1 and XRCC-1 DNA repair proteins.
Yadav A; Kumar B; Teknos TN; Kumar P
Mol Cancer Ther; 2011 Jul; 10(7):1241-51. PubMed ID: 21551262
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer.
Kim YB; Jeung HC; Jeong I; Lee K; Rha SY; Chung HC; Kim GE
J Radiat Res; 2013 Jan; 54(1):52-60. PubMed ID: 22923745
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
Martinelli E; Troiani T; Morgillo F; Rodolico G; Vitagliano D; Morelli MP; Tuccillo C; Vecchione L; Capasso A; Orditura M; De Vita F; Eckhardt SG; Santoro M; Berrino L; Ciardiello F
Clin Cancer Res; 2010 Oct; 16(20):4990-5001. PubMed ID: 20810384
[TBL] [Abstract][Full Text] [Related]
20. Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
Locatelli SL; Giacomini A; Guidetti A; Cleris L; Mortarini R; Anichini A; Gianni AM; Carlo-Stella C
Leukemia; 2013 Aug; 27(8):1677-87. PubMed ID: 23360848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]